Representativeness of surgical controls in aortic valve replacement trials: comparison with routine surgical cohorts

Heart, Artery and Coronary DiseasesTherapy and Intervention

Transcatheter vs. surgical aortic valve replacement in women: the RHEIA trial

Eur Heart J

Tchetche D, Pibarot P, Bax JJ, Bonaros N, Windecker S, Dumonteil N, Nietlispach F, Messika-Zeitoun D, Pocock SJ, Berthoumieu P, Swaans MJ, Timmers L, Rudolph TK, Bleiziffer S, Leroux L, Modine T, van der Kley F, Auffret V, Tomasi J, Stastny L, Hengstenberg C, Andreas M, Leclercq F, Gandet T, Mascherbauer J, Trescher K, Prendergast B, Vasa-Nicotera M, Chieffo A, Mares J, Wesselink W, Rakova R, Kurucova J, Bramlage P, Eltchaninoff H

doi: 10.1093/eurheartj/ehaf133

Heart, Artery and Coronary DiseasesFurther Publications

Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison

Clin Res Cardiol

Saad M, Seoudy H, Bramlage K, Bramlage P, Voran JC, Puehler T, Lutter G, Allali A, Landt M, Frank J, Bisht O, Salem M, Wienemann H, Adam M, Zeus T, Veulemans V, Bleiziffer S, Rudolph TK, Frank D

doi: 10.1007/s00392-025-02611-w

Heart, Artery and Coronary DiseasesTherapy and Intervention

5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

J Am Coll Cardiol

Forrest JK, Yakubov SJ, Deeb GM, Gada H, Mumtaz MA, Ramlawi B, Bajwa T, Crouch J, Merhi W, Wai Sang SL, Kleiman NS, Petrossian G, Robinson NB, Sorajja P, Iskander A, Berthoumieu P, Tchétché D, Feindel C, Horlick EM, Saito S, Oh JK, Jung Y, Reardon MJ, Low Risk Trial Investigators

doi: 10.1016/j.jacc.2025.03.004

Heart, Artery and Coronary DiseasesTherapy and Intervention

ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial

Lancet

Makkar RR, Ramana RK, Gnall E, Ramlawi B, Cheng W, Diamantouros P, Potluri S, Kleinman N, Gupta A, Chakravarty T, Samy S, Rassi A, Rajagopal V, Yakubov S, Sorajja P, Patel D, Garcia S, Yadav P, Thourani V, Wang J, Rinaldi M, Kapadia S, Waksman R, Webb J, Ren CB, Gregson J, Modolo R, Sathananthan J, Reardon MJ, ACURATE IDE study investigators

doi: 10.1016/S0140-6736(25)00319-8

Heart, Artery and Coronary DiseasesTherapy and Intervention

Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early After Surgical Bioprosthetic Valve Replacement: A Randomized Clinical Trial

Circ Cardiovasc Interv

Izumi C, Amano M, Yoshikawa Y, Fukushima S, Yaku H, Eishi K, Sakaguchi T, Ohno N, Hiraoka A, Okada K, Saiki Y, Miura T, Komiya T, Minami M, Yamamoto H, Omae K, ENBALV Trial Investigators

doi: 10.1161/CIRCINTERVENTIONS.124.015108

Heart, Artery and Coronary Diseases

Five-year outcomes of transcatheter versus surgical aortic valve replacement in women: A systematic review and meta-analysis

Eur J Cardiothorac Surg

Wolf SEM, Kucera JA, Gregg AC, Di Franco A, Rahouma M, Redfors B, Reardon M, Pineda AM, Gaca JA, Zwischenberger BA

doi: 10.1093/ejcts/ezaf400

Heart, Artery and Coronary DiseasesTherapy and Intervention

Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis: the DEDICATE-DZHK6 trial

Eur Heart J

Bleiziffer S, Leuschner F, Rudolph TK, Vonthein R, Meyer AL, Haeusler KG, Hofmann U, Gorski A, Hagendorff A, Kim WK, Baumgartner H, Borger MA, Choi YH, Cremer J, Falk V, Frey N, Hagl C, König IR, Landmesser U, Massberg S, Reichenspurner H, Renker M, Thiele H, Walther T, Ziegler A, Blankenberg S, Dreger H, Arif R, Unbehaun A, Seiffert M, DEDICATE Study Investigators

doi: 10.1093/eurheartj/ehaf519

Heart, Artery and Coronary DiseasesTherapy and Intervention

End of Life After Transcatheter Aortic Valve Replacement: A Danish Nationwide Cohort Study

JACC Cardiovasc Interv

Strange JE, Holt A, Christensen DM, Nouhravesh N, Petersen JK, Bække PS, De Backer O, Schou M, Køber L, Fosbøl EL

doi: 10.1016/j.jcin.2024.09.021

Atrial FibrillationTherapy and Intervention

Impact of statin treatment on postoperative atrial fibrillation in surgical aortic valve replacement

Am Heart J

Krasniqi L, Skovbo JS, Hallas PJ, Brandes PA, Mortensen PE, Gerke PO, Ravn EJ, Poulsen V, Modrau APIS, Müllertz KM, Dahl APJS, Riber PLP

doi: 10.1016/j.ahj.2025.06.005

Related content

Transcatheter vs. surgical aortic valve replacement in women: the RHEIA trial

Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison

5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial

Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early After Surgical Bioprosthetic Valve Replacement: A Randomized Clinical Trial

Five-year outcomes of transcatheter versus surgical aortic valve replacement in women: A systematic review and meta-analysis

Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis: the DEDICATE-DZHK6 trial

End of Life After Transcatheter Aortic Valve Replacement: A Danish Nationwide Cohort Study

Impact of statin treatment on postoperative atrial fibrillation in surgical aortic valve replacement